Dr. David A. Clump

Jondavid Pollock is a Radiation Oncologist in Wheeling, West Virginia. Dr. Pollock is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Laryngeal Cancer, and Pleuropulmonary Blastoma. Dr. Pollock is currently accepting new patients.

Christopher Wilke, MD, specializes in radiation oncology and is board-certified in radiation oncology by the American Board of Radiology. He practices at Mary Hillman Jennings Radiation Oncology Center and is affiliated with UPMC St Margaret, UPMC Children's Hospital of Pittsburgh, UPMC Magee-Womens Hospital, UPMC Passavant, UPMC East, UPMC Presbyterian, UPMC Shadyside, and UPMC Mercy. Dr. Wilke completed his fellowship at University of Texas MD Anderson Cancer Center and residency and medical education at University of Minnesota School of Medicine. Dr. Wilke is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Optic Glioma, Throat Cancer, Laryngeal Cancer, and Olfactory Neuroblastoma.

Heath D. Skinner, MD, PhD, is chair and medical director of the Department of Radiation Oncology and professor at UPMC Hillman Cancer Center, specializing in the study and treatment of head and neck and lung cancer. Dr. Skinner's research is designed to generate insights that led to the rational design of clinical trials using agents that are currently under investigation to minimize the time from bench to bedside. Dr. Skinner is board-certified in radiation oncology. He completed a combined MD/PhD program at West Virginia University. Upon completion of medical school, he began a combined internship and residency in radiation oncology at the University of Texas MD Anderson Cancer Center (MDACC). Over the course of his career, Dr. Skinner has received eight peer-reviewed grants, including a two current R01s funding his research. He has published over 85 peer-reviewed articles , has written 6 book chapters and 9 invited reviews and presented over 50 abstracts at national meetings. Dr. Skinner has also been invited to present his work at multiple domestic and international symposia. In addition to his research, Dr. Skinner is dedicated to providing excellent and compassionate patient care. This dedication is borne out in patient experience measures, with his scores being almost uniformly in the 99th percentile for all categories asked. Moreover, his patients have rated him in the top 1 percent nationally on Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) measures related to their experience with him in his clinic. Dr. Skinner is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Esophageal Cancer, Anaplastic Thyroid Cancer, Lung Cancer, and Gastrostomy.